Muhammad saif ur rehman babar

Muhammad saif ur rehman babar


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2023 in Materials Proceedings
Verified
Conference Paper
Open access
PDF file
SASaman Anwar
Saman Anwar
SASidra Altaf
Sidra Altaf
MBMuhammad saif ur rehman babar
Muhammad saif ur rehman babar
BABilal Aslam
Bilal Aslam
HMHumaira Muzaffar
Humaira Muzaffar
Arslan IftikharArslan Iftikhar
Arslan Iftikhar
The development of bacterial resistance toward existing antibiotics is a universal problem for human and animal health as well as for food security. In an attempt to overcome this problem, nanotechnology has contributed in the form of nanoformulations. However, these are associated with risks and drawbacks including environmental toxicity, cell injury, issues of high production cost and the scarcity of active ingredients. On the other hand, the green synthesis of nanoformulations via biological methods is a simple, innovative, ecofriendly, cost effective and advanced approach for the treatment of lethal infections caused by multidrug-resistant organisms such as staphylococcus aureus. About 30% of humans are asymptomatic carriers of S. aureus in their upper respiratory tract. Clinical diseases caused by S. aureus infections range from mild to severe and may be manifested in the form of pneumonia, osteomyelitis, skin and deep tissue infections. Here, we prepared plant-mediated gold nanoparticles from Camellia sinensis and Cocos nucifera. The green biocompatible nanoparticles were characterized by using UV-Visible spectroscopy (UV-Vis. spectroscopy), X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), dynamic light scattering (DLS) and Fourier transform infrared spectroscopy (FTIR). Moreover, these green gold nanoparticles were investigated for their antimicrobial activity by checking their minimum inhibitory concentrations (MICs). We found that the newly developed bio-nanoparticles showed strong activity against the multidrug-resistant Staphylococcus aureus.